SE7607037L - Forfarande for framstellning av antibiotika - Google Patents
Forfarande for framstellning av antibiotikaInfo
- Publication number
- SE7607037L SE7607037L SE7607037A SE7607037A SE7607037L SE 7607037 L SE7607037 L SE 7607037L SE 7607037 A SE7607037 A SE 7607037A SE 7607037 A SE7607037 A SE 7607037A SE 7607037 L SE7607037 L SE 7607037L
- Authority
- SE
- Sweden
- Prior art keywords
- hydrogen
- syn
- furyl
- thienyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB26188/75A GB1555471A (en) | 1975-06-19 | 1975-06-19 | 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7607037L true SE7607037L (sv) | 1976-12-20 |
Family
ID=10239713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7607037A SE7607037L (sv) | 1975-06-19 | 1976-06-18 | Forfarande for framstellning av antibiotika |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4074047A (enExample) |
| JP (1) | JPS5214793A (enExample) |
| AT (1) | AT353956B (enExample) |
| AU (1) | AU505041B2 (enExample) |
| BE (1) | BE843152A (enExample) |
| CH (1) | CH625526A5 (enExample) |
| DE (1) | DE2627212A1 (enExample) |
| DK (1) | DK272676A (enExample) |
| ES (1) | ES449032A1 (enExample) |
| FR (1) | FR2315933A1 (enExample) |
| GB (1) | GB1555471A (enExample) |
| NL (1) | NL7606614A (enExample) |
| SE (1) | SE7607037L (enExample) |
| ZA (1) | ZA763635B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5517823B2 (enExample) * | 1972-05-16 | 1980-05-14 | ||
| JPS4986668A (enExample) * | 1972-12-27 | 1974-08-20 | ||
| US4175185A (en) * | 1976-05-19 | 1979-11-20 | Meiji Seika Kaisha Ltd. | Process for preparing cephalosporanic acid derivatives |
| GB1591439A (en) * | 1976-10-01 | 1981-06-24 | Glaxo Operations Ltd | 7-syn (oxyimino -acylamido) cephalosporins |
| GB1596278A (en) * | 1976-11-30 | 1981-08-26 | Glaxo Operations Ltd | 7-(-oxyimino-acetamino)cephalosporin derivatives |
| US4208517A (en) * | 1976-11-30 | 1980-06-17 | Glaxo Operations Uk Limited | Caphalosporin compounds having at position-7 an α-etherified hydroxyiminoarylacetamido group |
| NL7805715A (nl) * | 1977-06-03 | 1978-12-05 | Hoffmann La Roche | Werkwijze voor het bereiden van acylderivaten. |
| EP0059486B1 (en) * | 1978-07-17 | 1985-10-02 | Fujisawa Pharmaceutical Co., Ltd. | New starting compounds for preparing cephem compounds and processes for their preparation |
| FI782683A7 (fi) * | 1978-07-19 | 1980-01-20 | Hoffmann La Roche | Kefalosporinestrar och -estrar |
| US4284631A (en) * | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
| US4198504A (en) * | 1978-11-02 | 1980-04-15 | Bristol-Myers Company | [3-(Pyridinium)-7-(naphthyiridinyl carbonylamino)acetamido]cephalosporanic acid derivatives |
| US4337376A (en) * | 1979-12-31 | 1982-06-29 | Broadcom, Incorporated | Communications system and network |
| US7427680B2 (en) * | 2001-01-12 | 2008-09-23 | The Regents Of The University Of California | Fluorogenic substrates for BETA-lactamase gene expression |
| WO2005071096A2 (en) * | 2004-01-21 | 2005-08-04 | Molecular Probes, Inc. | Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample |
| CN114478149B (zh) * | 2022-01-18 | 2023-09-15 | 吉林化工学院 | 一种羧酸类化合物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1389194A (en) * | 1971-01-29 | 1975-04-03 | Glaxo Lab Ltd | Antibiotics |
| US3971778A (en) * | 1972-05-12 | 1976-07-27 | Glaxo Laboratories Limited | Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position |
| GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
| GB1453049A (en) * | 1973-08-21 | 1976-10-20 | Glaxo Lab Ltd | Cephalosporing antibiotics |
| DE2262500A1 (de) * | 1972-12-20 | 1973-07-05 | Lilly Co Eli | 3-oxyiminomethylcephalosporinverbindungen |
| DE2460537C2 (de) * | 1973-12-21 | 1987-01-22 | Glaxo Laboratories Ltd., Greenford, Middlesex | 7-β-Acylamido-3-em-4-carbonsäure-Antibiotika |
-
1975
- 1975-06-19 GB GB26188/75A patent/GB1555471A/en not_active Expired
-
1976
- 1976-06-09 US US05/694,465 patent/US4074047A/en not_active Expired - Lifetime
- 1976-06-18 BE BE168099A patent/BE843152A/xx not_active IP Right Cessation
- 1976-06-18 CH CH784176A patent/CH625526A5/de not_active IP Right Cessation
- 1976-06-18 DK DK272676A patent/DK272676A/da not_active Application Discontinuation
- 1976-06-18 AT AT445876A patent/AT353956B/de not_active IP Right Cessation
- 1976-06-18 ZA ZA763635A patent/ZA763635B/xx unknown
- 1976-06-18 FR FR7618662A patent/FR2315933A1/fr active Granted
- 1976-06-18 SE SE7607037A patent/SE7607037L/xx unknown
- 1976-06-18 NL NL7606614A patent/NL7606614A/xx not_active Application Discontinuation
- 1976-06-18 AU AU15032/76A patent/AU505041B2/en not_active Expired
- 1976-06-18 DE DE19762627212 patent/DE2627212A1/de not_active Withdrawn
- 1976-06-18 JP JP51072692A patent/JPS5214793A/ja active Pending
- 1976-06-18 ES ES449032A patent/ES449032A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU505041B2 (en) | 1979-11-08 |
| NL7606614A (nl) | 1976-12-21 |
| US4074047A (en) | 1978-02-14 |
| DE2627212A1 (de) | 1977-01-13 |
| FR2315933A1 (fr) | 1977-01-28 |
| FR2315933B1 (enExample) | 1979-10-12 |
| BE843152A (fr) | 1976-12-20 |
| ES449032A1 (es) | 1977-11-16 |
| AU1503276A (en) | 1977-12-22 |
| AT353956B (de) | 1979-12-10 |
| ATA445876A (de) | 1979-05-15 |
| CH625526A5 (enExample) | 1981-09-30 |
| ZA763635B (en) | 1977-05-25 |
| JPS5214793A (en) | 1977-02-03 |
| DK272676A (da) | 1976-12-20 |
| GB1555471A (en) | 1979-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES449032A1 (es) | Un procedimiento mejorado para la preparacion de antibioti- cos a base de compuestos de cefalosporina. | |
| SE7904576L (sv) | Cefalosporinantibiotika | |
| ES399267A1 (es) | Un procedimiento para la preparacion de cefalosporinas. | |
| ES429388A1 (es) | Procedimiento para la preparacion de antibioticos de acido 7-(2-aril-2(oxiimino eterificado)acetamido)-3-carbamoiloxi- metilcef-3-em-4-carboxilico. | |
| SE7504999L (sv) | Cefalosporiner med -acylaminoettiksyrasidokedja. | |
| SE7611047L (sv) | Forfarande for framstellning av antibakteriella emnen | |
| ES480916A1 (es) | Un procedimiento para la preparacion de antibioticos de ce- falosporina. | |
| IE42144L (en) | Cephalosporin compounds. | |
| ES485441A1 (es) | Un procedimiento para la preparacion de antibioticos de ce- falosporina | |
| ES486023A1 (es) | Un procedimiento para la preparacion de antibioticos de ce- falosporina | |
| GB1496757A (en) | Cephalosporin derivatives | |
| ES459945A1 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. | |
| SE7713521L (sv) | Forfarande for framstellning av antibiotika | |
| IE38869L (en) | Cephalosporin compounds | |
| ES8103104A1 (es) | Un procedimiento para la preparacion de un antibiotico de cefalosporina. | |
| ES485434A1 (es) | Un procedimiento para la preparacion de antibioticos de ce- falosporina | |
| SE7509139L (sv) | Forfarande for framstellning av cefalosporinforeningar | |
| ES464123A1 (es) | Un procedimiento para la preparacion de esteres de acido clavulanico. | |
| ES8504815A1 (es) | Un procedimiento para la preparacion de nuevos derivados de penem 2-tiosustituidos | |
| SE8002217L (sv) | Cefalosporinantibiotika | |
| ES456083A1 (es) | Un procedimiento para la preparacion de nuevas cefalospori- nas. | |
| GB1522140A (en) | Syn-7-(2-hydroxyiminoacetamido)-3-pyridiniummethyl cephalosporins methods for their preparation and compositions containing them | |
| GB1389195A (en) | Antibiotics | |
| FR2426692A1 (fr) | Antibiotiques du type cephalosporine et leur procede de preparation | |
| DE3171431D1 (en) | Derivatives of 7-beta-(ketoximinoacylamido)-ceph-3-em-4-carboxylic acids, process for their preparation and their pharmaceutical compositions containing them |